Overview This page contains the latest trade data of Tetracyclines, derivatives, in bulk, salts. In 2022, Tetracyclines, derivatives, in bulk, salts were the world's 2408th most traded product, with a total trade of $825M. Between 2021 and 2022 the exports of Tetracyclines, derivatives, in bulk, salts grew by 7.87%, from $764M to $825M. Trade in Tetracyclines, derivatives, in bulk, salts represent 0.0035% of total world trade.
Tetracyclines, derivatives, in bulk, salts are a part of Antibiotics.
Exports In 2022 the top exporters of Tetracyclines, derivatives, in bulk, salts were N/A.
Imports In 2022 the top importers of Tetracyclines, derivatives, in bulk, salts were Italy ($119M), Belgium ($94.9M), India ($53.9M), Netherlands ($52.8M), and United States ($45.2M).
Ranking Tetracyclines, derivatives, in bulk, salts ranks 1202nd in the Product Complexity Index (PCI).
Description Tetracyclines are a family of broad-spectrum antibiotics which are used to combat a wide variety of bacterial infections. Derivatives of this family include doxycycline and minocycline. Doxycycline is primarily used to treat respiratory tract infections, acne, and chlamydia. Minocycline is used to treat acne, periodontitis, and rheumatoid arthritis.